This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Biomerieux, Inc., Commissariat a L'energie Atomique Et Aux Energies Alternatives. Active years: 2017.
Company Filing History:
1 out of 645 
1 out of 8,807 
Years Active: 2017
Title: Janie Dassa: Innovator in RNA Polymerase Technology
Introduction
Janie Dassa is a prominent inventor based in Palaiseau, France. She has made significant contributions to the field of molecular biology, particularly through her work on RNA polymerases. Her innovative approach has led to advancements that are crucial for various applications in biotechnology.
Latest Patents
Janie Dassa holds a patent for a mutated T7 RNA polymerase. This invention pertains to a mutated T7 RNA polymerase that is altered at position 744, where the glutamine (Q) is replaced by an amino acid selected from arginine (Q744R), leucine (Q744L), or proline (Q744P). This development has potential implications for enhancing the efficiency of RNA synthesis.
Career Highlights
Throughout her career, Janie has worked with notable organizations, including bioMérieux, Inc. and the Commissariat à l'énergie atomique et aux énergies alternatives. Her experience in these institutions has allowed her to refine her skills and contribute to groundbreaking research in her field.
Collaborations
Janie has collaborated with esteemed colleagues such as Jean-Claude Boulain and Frédéric Ducancel. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Janie Dassa's work in the field of RNA polymerases exemplifies her dedication to scientific advancement. Her patented innovations and collaborative efforts continue to influence the biotechnology landscape.